Enzyme Contract Manufacturing Global Market to Propel Significantly at a CAGR of ~8% by 2028 | DelveInsight

New York, USA, June 14, 2023 (GLOBE NEWSWIRE) — Enzyme Contract Manufacturing Global Market to Propel Significantly at a CAGR of ~8% by 2028 | DelveInsight

The enzyme contract manufacturing market dynamics are anticipated to change in the coming years owing to the burgeoning pharmaceutical and healthcare sectors, rising diagnostic and therapeutic value of enzymes, and more research and development. Furthermore, the expanding food and beverage sector, detergent industry, paper and textile industry, innovations, and new enzyme product launches are driving enzyme contract manufacturing favorable market growth from 2023 to 2028.

DelveInsight’s Enzyme Contract Manufacturing Market Insights report provides the current and forecast market analysis, individual leading enzyme contract manufacturing companies’ market shares, challenges, enzyme contract manufacturing market drivers, barriers, trends, and key market enzyme contract manufacturing companies in the market.

Key Takeaways from the Enzyme Contract Manufacturing Market Report

• As per DelveInsight estimates, North America is anticipated to dominate the global enzyme contract manufacturing market during the forecast period. 
• Notable enzyme contract manufacturing companies such as EKF Diagnostics Holdings plc, Enzyme Bioscience, SEKISUI CHEMICAL CO., LTD., Creative Enzymes, Enzymology Research Center, Inc., Prozomix Limited, Tex Biosciences (P) Ltd, IBEX Technologies Inc., BRAIN Biotech AG, Meteoric Biopharmaceuticals Limited, Biovencer Healthcare Private Limited, Careprobio, Indus Gene, OENON Holdings, Inc., Ikeda Tohka Industries Co., Ltd, and several others, are currently operating in the enzyme contract manufacturing market.
• In May 2021, BRAIN Biotech AG, acquired Biocatalysts Ltd. and has purchased an additional 16.7% of Biocatalysts Ltd. as two minority shareholders have exercised their put option rights. BRAIN now holds a total of 82.2% (previously 65.55%) in the daughter company. The purchase price was GBP 3.9 million.

To read more about the latest highlights related to the enzyme contract manufacturing market, get a snapshot of the key highlights entailed in the Global Enzyme Contract Manufacturing Market Report

Enzyme Contract Manufacturing Overview

Enzyme contract manufacturing is the synthesis of enzymes by professionals with substantial expertise and experience in the development, optimization, and scaling up of enzyme production systems. Enzyme contract manufacturing entails the infrastructure, equipment, and employees required to create enzymes in large quantities at a lower cost than in-house production.

Enzyme Contract Manufacturing Market Insights

North America held the greatest share of the enzyme contract manufacturing market in 2022, with 36.23%. The increasing food and beverage industry, rising trend of contract manufacturing, and others in the region will all influence the growth of the microbe enzymes contract manufacturing market in North America. Furthermore, the presence of prominent competitors, as well as increased research and development activities pertaining to enzymes, are driving the market expansion of the enzyme contract manufacturing market in North America.

Enzymes such as pectinases, amylases, and others are widely utilized in the beverage processing industry in the United States to boost yield and improve processes such as extraction, clarity, and aroma enhancement when compared to their chemical counterparts. In addition, the existence of important players in the US, such as Creative Enzymes, Enzymology Research Centre, Inc., and other manufacturers, would aid in providing the best contract microbe enzyme production services, raising demand in the region.

To know more about why North America is leading the market growth in the enzyme contract manufacturing market, get a snapshot of the Enzyme Contract Manufacturing Market Outlook 

Enzyme Contract Manufacturing Market Dynamics

The increasing therapeutic value of enzymes is one of the primary factors fueling the growth of the enzymes contract manufacturing market. Enzymes from various origins, including plant, animal, and microbial, have emerged as viable therapeutic solutions for diverse pathologies in recent years, which is projected to fuel the enzyme contract manufacturing market growth in the approaching years. The therapeutic value of a variety of enzymes, including lipases, collagenases, and others, has been emphasized in a number of research articles, leading to an increased focus of pharmaceutical and biotech companies on developing enzyme-based drugs and therapies.

Furthermore, the numerous advantages associated with enzymes, such as their ability to bind and act on their targets with high affinity and specificity, and their ability to convert multiple target molecules into desired products, among others, make enzymatic treatment of diseases more effective than established therapeutic approaches. They are used alone or in combination with other medicines to treat a variety of disorders in an effective and safe manner. Moreover, as the prevalence of certain diseases, such as cardiovascular disease, cancer, HIV, skin diseases, and others, rise, therapeutic enzymes may become increasingly important in their treatment and control.

However, the need for precise pH and temperature settings and the difficulties involved in enzyme purification and isolation may limit the growth of the enzyme contract manufacturing market.

Get a sneak peek at the enzyme contract manufacturing market dynamics @ Enzyme Contract Manufacturing Market Dynamics Analysis

Enzyme Contract Manufacturing Market Assessment

• Enzyme Contract Manufacturing Market Segmentation
  • Enzyme Contract Manufacturing Market Segmentation By  Source: Plant, Animal, Microbe), Application (Industrial Enzymes [Food and Beverages, Animal Feed, Detergent, Paper and Others], Specialty Enzymes [Pharmaceutical Manufacturing, Diagnostic, Research And Development, and Others]
  • Enzyme Contract Manufacturing Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
• Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the enzyme contract manufacturing market are set to emerge as the trendsetter explore @ Enzyme Contract Manufacturing Companies 

Table of Contents 

Interested in knowing the enzyme contract manufacturing market by 2028? Click to get a snapshot of the Enzyme Contract Manufacturing Market Trends

Related Reports

Contract Development Manufacturing Organization Market

Contract Development Manufacturing Organization Market Insight, Competitive Landscape, and Market Forecast – 2028 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key contract development manufacturing organization companies such as Patheon (Thermo Fisher Scientific), Catalent,Inc, Laboratoire Elaiapharm, The Lubrizol Corporation, among others.

Biopharmaceuticals Contract Manufacturing Market

Biopharmaceuticals Contract Manufacturing Market Insight, Competitive Landscape, and Market Forecast – 2028 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key biopharmaceuticals contract manufacturing companies such as Boehringer Ingelheim International GmbH, Lonza, Rentschler Biopharma SE, among others.

Medical Device Contract Manufacturing Market

Medical Device Contract Manufacturing Market Insight, Competitive Landscape, and Market Forecast – 2028 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key medical device contract manufacturing companies such as Flex, Ltd., Integer Holdings Corporation, Gerresheimer AG, Sanmina Corporation, Nipro Corporation, Celestica International Lp., Plexus Corp., Benchmark Electronics Inc., and West Pharmaceutical Services, Inc., among others.

ELISA Market

ELISA Market Insight, Competitive Landscape, and Market Forecast – 2028 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key ELISA companies such as Abbott, F. Hoffmann-La Roche Ltd, Erba Mannheim, Synbiotik, Maccura Biotechnology Co., Ltd., Thermo Fisher Scientific, DiaSorin, PerkinElmer Inc., Diatron, Werfen, ALPCO, Agilent, InBios International Inc., Awareness Technology Inc., Elabscience Biotechnology Inc., among others.

Cancer Therapy Market

Cancer Therapy Market Insight, Competitive Landscape, and Market Forecast – 2028 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key cancer therapy companies, including GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, AbbVie Inc., Amgen Inc, Sanofi, among others.

Oncology Drugs Market

Oncology Drugs Market Insight, Competitive Landscape, and Market Forecast – 2028 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key oncology drugs companies, including GlaxoSmithKline, Eli Lilly & Company, F. Hoffmann-La Roche Ltd, among others.

Other Trending Reports

Alopecia Market | Invasive Candidiasis Market | Bronchial Spasm Market | Chronic Gout Market | Hpv-Induced Cancers Market | Meningioma Market | Lewy Body Dementia Market | Anti-Gbm Disease Market | Colorectal Cancer CRC Market | Cervical Intraepithelial Neoplasia Market | Carpal Tunnel Syndrome Market | Nonalcoholic Steatohepatitis Market | AIDS Related Kaposis Sarcoma Market | Progressive Supranuclear Palsy Market | Tropical Spastic Paraparesis Market | Secondary Progressive Multiple Sclerosis SPMS Market | Systemic Sclerosis-Associated Interstitial Lung Disease Market | Reactive Airway Disease Market | Ptosis Market | AL Amyloidosis Market | Abdominal Aortic Aneurysm Market | X-Linked Retinitis Pigmentosa Market

Related Healthcare Services

Healthcare Consulting

Healthcare Competitive Intelligence Services

Healthcare Asset Prioritization Services

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.